Cite
HARVARD Citation
Urup, T. et al. (2016). Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan. Acta oncologica. pp. 418-422. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Urup, T. et al. (2016). Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan. Acta oncologica. pp. 418-422. [Online].